<DOC>
	<DOCNO>NCT03026907</DOCNO>
	<brief_summary>The purpose study compare efficacy alitretinoin azathioprine treatment patient severe chronic non-hyperkeratotic hand eczema .</brief_summary>
	<brief_title>Alitretinoin v Azathioprine Severe Non-hyperkeratotic Hand Eczema</brief_title>
	<detailed_description />
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Alitretinoin</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Age ≥ 18 year ≤ 75 year Severe severe chronic nonhyperkeratotic hand eczema minimum duration 3 month define Physician Global Assessment ( PGA ) use validate Photoguide Refractory standard therapy , define : Patients receive treatment topical corticosteroid class II high least 8 week within 3 month enrolment , either response transient response . Patients also receive standard skin care , include emollient barrier protection appropriate , without significant improvement . Patients avoid irritant allergen , identify , without significant improvement . Women childbearing potential require use least two form contraception least 1 month start treatment , treatment , least 1 month finishing treatment ; woman require take monthly pregnancy test Able provide write Informed Consent Able speak read Dutch language General criterion prior randomization Treatment alitretinoin azathioprine previous 3 month Hyperkeratotic palmar eczema define Danish Contact Dermatitis Group Patients predominantly atopic dermatitis , hand also involve . Patients mild atopic dermatitis , hand mainly affect eligible inclusion . Psoriasis Active bacterial , fungal , viral infection hand Pregnant/lactating plan become pregnant study period Treatment systemic medication UV radiation within previous 4 week Mentally incompetent Immunocompromised status Known suspect allergy ingredient study medication Inclusion study investigational drug within 60 day prior start treatment Current malignancy ( successfully treat nonmetastatic cutaneous squamous cell basal cell carcinoma and⁄or localize carcinoma situ cervix ) Current active pancreatitis Living vaccine ( include bacillus CalmetteGuérin ( BCG ) , varicella , measles , mumps , rubella , yellow fever , oral polio oral typhoid ) last 2 week plan application vaccine study period Evidence alcohol abuse drug addiction Chronic recurrent infectious disease Contact sensitization clinical relevance hand , exposure allergen avoid Hypervitaminosis A due use vitamin A supplement contain &gt; 2000 IU Use drug potential change effective dosis study drug within previous 2 week Laboratory exclusion criterion post randomization Alanine aminotransferase ( ALAT ) ⁄or aspartate aminotransferase ( ASAT ) value &gt; 200 % upper limit normal Impaired renal function indicate clinically relevant abnormal creatinine value ( determined investigator treat physician ) Anemia indicate clinically relevant lower hemoglobin value ( determined investigator treat physician ) Alitretinoin specific Triglycerides &gt; 200 % upper limit normal , Cholesterol low density lipoprotein ( LDL ) cholesterol value &gt; 200 % upper limit normal Uncontrolled hypothyroidism ( determined investigator treat physician ) Azathioprine specific • Patients low absent thiopurine methyltransferase ( TPMT ) activity ( define center &lt; 52 nmol/gHb/hour , combine genotyping show homozygous compound heterozygous mutation ) subsequent risk lifethreatening myelotoxicity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Alitretinoin</keyword>
	<keyword>Azathioprine</keyword>
	<keyword>Hand eczema</keyword>
</DOC>